Search Results (1 to 10 of 1539 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 434 Journal of Medical Internet Research
- 279 JMIR Research Protocols
- 182 JMIR Formative Research
- 128 JMIR mHealth and uHealth
- 82 JMIR Public Health and Surveillance
- 69 Online Journal of Public Health Informatics
- 56 JMIR Mental Health
- 40 JMIR Medical Informatics
- 39 JMIR Human Factors
- 26 JMIR Cancer
- 22 JMIR Dermatology
- 21 JMIR Medical Education
- 19 Interactive Journal of Medical Research
- 19 JMIR Serious Games
- 18 JMIR Aging
- 18 JMIR Pediatrics and Parenting
- 14 JMIRx Med
- 11 Iproceedings
- 11 JMIR Diabetes
- 10 JMIR Infodemiology
- 9 JMIR Rehabilitation and Assistive Technologies
- 8 JMIR Perioperative Medicine
- 7 JMIR AI
- 4 JMIR Nursing
- 4 Journal of Participatory Medicine
- 3 JMIR Cardio
- 2 JMIR Biomedical Engineering
- 2 JMIR Neurotechnology
- 1 JMIR Data
- 1 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 Asian/Pacific Island Nursing Journal
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

Sodium oxybate, the pharmacological agent used in this study, acts as a GABA-B receptor agonist and a precursor of GABA [24]. It was administered in doses ranging between 0.01 and 0.1 g/kg, 3 times daily either orally or intravenously (equivalent to 2.4-24 g/d for an 80 kg patient). Among patients with schizophrenia and catatonia, approximately 30 participants, the study showed a reduction of catatonic symptoms ranging from 60% to 70%.
JMIR Res Protoc 2025;14:e68356
Download Citation: END BibTex RIS

(B) Two scenarios of exclusion. Left: the onset (day 4) meets the definition, but the pain severity is at the personal median pain level, conflicting with the criterion for the end of a pain flare. Right: 2 flare onsets (days 2 and 4) meet the definition but end on the same day (day 5). The second onset (day 4) is removed to avoid double counting.
In addition to identifying pain flares by their severity, we examined their residual impact in the postflare phase.
JMIR Mhealth Uhealth 2025;13:e64889
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section

Conversational Systems for Social Care in Older Adults: Protocol for a Scoping Review
JMIR Res Protoc 2025;14:e72310
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section